Fig. 1From: Cisplatin-based concurrent chemoradiotherapy improved the survival of locoregionally advanced nasopharyngeal carcinoma after induction chemotherapy by reducing early treatment failureDifferent cut-off thresholds with corresponding P values for locoregional failure (A) and distant failure (B)Back to article page